Look at the headline -- Big and Bold: Health Canada Authorizes EMERGENCY USE of Leronlimab
Nowhere in the Health Canada Special Access Program do they use the term EMERGENCY USE. Looking at the numerous social media posts, many were referencing EUA so they were deceived as to what this was.
Nowhere in the press release did NP actually say Special Access Program at ALL. If he had been honest he would have stated the exact program, instead he tried to imply it was an EUA by using EMERGENCEY USE repeatedly in the press release.
NP is notorious for misleading press releases that's why he is under investigation by the SEC, the DOJ and under a shareholder class action suit for stock fraud. This is just another example of spinning a more positive story through attempting to deceive investors. It is dishonest.
News 
Market Data 
Discover 
